Oksana Volod

500 total citations
33 papers, 319 citations indexed

About

Oksana Volod is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Oksana Volod has authored 33 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Oksana Volod's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Mechanical Circulatory Support Devices (8 papers). Oksana Volod is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Mechanical Circulatory Support Devices (8 papers). Oksana Volod collaborates with scholars based in United States, Austria and Czechia. Oksana Volod's co-authors include Oana Dumitrașcu, Patrick D. Lyden, Yao Wang, Valérie Biousse, Swaraj Bose, Francisco A. Arabía, L. Czer, Francesco Viola, J. Moriguchi and Daniel R. Margulies and has published in prestigious journals such as Annals of Internal Medicine, Critical Care Medicine and Medicine.

In The Last Decade

Oksana Volod

31 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oksana Volod United States 11 115 86 81 79 60 33 319
Stéphane Thierry France 7 42 0.4× 87 1.0× 53 0.7× 24 0.3× 21 0.3× 7 306
Ronald L. Kirshner United States 9 262 2.3× 81 0.9× 142 1.8× 24 0.3× 78 1.3× 12 395
Shane Urban United States 5 67 0.6× 74 0.9× 22 0.3× 27 0.3× 30 0.5× 14 326
Tristan Morichau-Beauchant France 7 38 0.3× 88 1.0× 55 0.7× 48 0.6× 181 3.0× 9 387
Allen Kong United States 11 150 1.3× 208 2.4× 104 1.3× 51 0.6× 137 2.3× 33 426
Odunayo Olorunfemi United States 13 153 1.3× 68 0.8× 304 3.8× 11 0.1× 54 0.9× 39 430
Paul Masi France 9 41 0.4× 14 0.2× 58 0.7× 27 0.3× 42 0.7× 25 257
Sang Ook Ha South Korea 12 133 1.2× 6 0.1× 58 0.7× 43 0.5× 150 2.5× 29 410
François Raymond Canada 7 125 1.1× 227 2.6× 133 1.6× 100 1.3× 28 0.5× 10 391
Suguru Ohira United States 12 235 2.0× 61 0.7× 157 1.9× 10 0.1× 53 0.9× 92 415

Countries citing papers authored by Oksana Volod

Since Specialization
Citations

This map shows the geographic impact of Oksana Volod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oksana Volod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oksana Volod more than expected).

Fields of papers citing papers by Oksana Volod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oksana Volod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oksana Volod. The network helps show where Oksana Volod may publish in the future.

Co-authorship network of co-authors of Oksana Volod

This figure shows the co-authorship network connecting the top 25 collaborators of Oksana Volod. A scholar is included among the top collaborators of Oksana Volod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oksana Volod. Oksana Volod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volod, Oksana, et al.. (2025). Anticoagulation Management During ECMO: Narrative Review. JHLT Open. 8. 100216–100216. 4 indexed citations
3.
Volod, Oksana, Modesto J. Colón, & Francisco A. Arabía. (2023). In Search of the Holy Grail of Artificial Hearts: Are We There Yet?. Seminars in Thrombosis and Hemostasis. 50(1). 104–114. 2 indexed citations
4.
Volod, Oksana, et al.. (2023). The TEG 5000 System: System Description and Protocol for Measurements. Methods in molecular biology. 2663. 725–733. 3 indexed citations
6.
Volod, Oksana, et al.. (2023). The TEG 6s System: System Description and Protocol for Measurements. Methods in molecular biology. 2663. 735–742. 7 indexed citations
7.
Volod, Oksana & Francesco Viola. (2023). The Quantra System: System Description and Protocols for Measurements. Methods in molecular biology. 2663. 743–761. 12 indexed citations
8.
Volod, Oksana, Connor M. Bunch, Ernest E. Moore, et al.. (2022). Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. Journal of Clinical Medicine. 11(3). 860–860. 61 indexed citations
9.
Volod, Oksana, Marian A. Rollins‐Raval, Andrew Goodwin, et al.. (2021). Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban. Archives of Pathology & Laboratory Medicine. 146(2). 145–153. 4 indexed citations
10.
Luthringer, Daniel, et al.. (2021). Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression. Medicine. 100(15). e25255–e25255. 3 indexed citations
11.
Dumitrașcu, Oana, Oksana Volod, Swaraj Bose, et al.. (2020). Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. Journal of Stroke and Cerebrovascular Diseases. 29(8). 104982–104982. 60 indexed citations
12.
Volod, Oksana, et al.. (2020). Platelet Mapping by Thromboelastography and Whole Blood Aggregometry in Adult Patients Supported by Mechanical Circulatory Support Device on Aspirin Therapy. Journal of ExtraCorporeal Technology. 52(1). 13–21. 10 indexed citations
13.
Melmed, Kara, Konrad Schlick, Oana Dumitrașcu, et al.. (2020). Assessing Cerebrovascular Hemodynamics Using Transcranial Doppler in Patients with Mechanical Circulatory Support Devices. Journal of Neuroimaging. 30(3). 297–302. 6 indexed citations
14.
Bloom, Matthew B., et al.. (2019). Improved prediction of HIT in the SICU using an improved model of the Warkentin 4-T system: 3-T. The American Journal of Surgery. 219(1). 54–57. 4 indexed citations
15.
Chandler, Wayne L., Dong Chen, Karen Moser, et al.. (2018). External Quality Assurance of Platelet Function Assays: Results of the College of American Pathologists Proficiency Testing Program. Archives of Pathology & Laboratory Medicine. 143(4). 472–482. 8 indexed citations
16.
Goldfarb, Michael, et al.. (2018). High Molecular Weight von Willebrand Factor Multimer Loss and Bleeding in Patients with Short-Term Mechanical Circulatory Support Devices: A Case Series. Journal of ExtraCorporeal Technology. 50(2). 77–82. 13 indexed citations
17.
Arabía, Francisco A., L. Czer, J. Moriguchi, et al.. (2017). Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart. Journal of Thrombosis and Haemostasis. 15(8). 1620–1624. 10 indexed citations
18.
Harada, Megan Y., Jason Murry, Oksana Volod, et al.. (2016). Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU*. Critical Care Medicine. 45(1). 28–34. 16 indexed citations
20.
Bloom, Matthew B., Rodrigo F. Alban, Rex Chung, et al.. (2015). Body mass index strongly impacts the diagnosis and incidence of heparin-induced thrombocytopenia in the surgical intensive care unit. The Journal of Trauma: Injury, Infection, and Critical Care. 80(3). 398–404. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026